192 related articles for article (PubMed ID: 31595685)
1. Targeted Exosomes for Drug Delivery: Biomanufacturing, Surface Tagging, and Validation.
Si Y; Kim S; Zhang E; Tang Y; Jaskula-Sztul R; Markert JM; Chen H; Zhou L; Liu XM
Biotechnol J; 2020 Jan; 15(1):e1900163. PubMed ID: 31595685
[TBL] [Abstract][Full Text] [Related]
2. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
[TBL] [Abstract][Full Text] [Related]
3. A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer.
Li Y; Gao Y; Gong C; Wang Z; Xia Q; Gu F; Hu C; Zhang L; Guo H; Gao S
Nanomedicine; 2018 Oct; 14(7):1973-1985. PubMed ID: 29935333
[TBL] [Abstract][Full Text] [Related]
4. Tumor Exosomes Reprogrammed by Low pH Are Efficient Targeting Vehicles for Smart Drug Delivery and Personalized Therapy against their Homologous Tumor.
Gong C; Zhang X; Shi M; Li F; Wang S; Wang Y; Wang Y; Wei W; Ma G
Adv Sci (Weinh); 2021 May; 8(10):2002787. PubMed ID: 34026432
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy.
Chen H; Gao J; Lu Y; Kou G; Zhang H; Fan L; Sun Z; Guo Y; Zhong Y
J Control Release; 2008 Jun; 128(3):209-16. PubMed ID: 18450313
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of doxorubicin to HER2 positive tumor models.
Gomari H; Forouzandeh Moghadam M; Soleimani M; Ghavami M; Khodashenas S
Int J Nanomedicine; 2019; 14():5679-5690. PubMed ID: 31413568
[TBL] [Abstract][Full Text] [Related]
7. Efficient exosome delivery in refractory tissues assisted by ultrasound-targeted microbubble destruction.
Sun W; Li Z; Zhou X; Yang G; Yuan L
Drug Deliv; 2019 Dec; 26(1):45-50. PubMed ID: 30744440
[TBL] [Abstract][Full Text] [Related]
8. Exosome-mimetic nanoplatforms for targeted cancer drug delivery.
Vázquez-Ríos AJ; Molina-Crespo Á; Bouzo BL; López-López R; Moreno-Bueno G; de la Fuente M
J Nanobiotechnology; 2019 Jul; 17(1):85. PubMed ID: 31319859
[TBL] [Abstract][Full Text] [Related]
9. Cellular Uptake and Cytotoxic Effect of Epidermal Growth Factor Receptor Targeted and Plitidepsin Loaded Co-Polymeric Polymersomes on Colorectal Cancer Cell Lines.
Goñi-de-Cerio F; Thevenot J; Oliveira H; Pérez-Andrés E; Berra E; Masa M; Suárez-Merino B; Lecommandoux S; Heredia P
J Biomed Nanotechnol; 2015 Nov; 11(11):2034-49. PubMed ID: 26554161
[TBL] [Abstract][Full Text] [Related]
10. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.
Tian Y; Li S; Song J; Ji T; Zhu M; Anderson GJ; Wei J; Nie G
Biomaterials; 2014 Feb; 35(7):2383-90. PubMed ID: 24345736
[TBL] [Abstract][Full Text] [Related]
11. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.
Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z
J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721
[TBL] [Abstract][Full Text] [Related]
12. Aspirin-loaded nanoexosomes as cancer therapeutics.
Tran PHL; Wang T; Yin W; Tran TTD; Nguyen TNG; Lee BJ; Duan W
Int J Pharm; 2019 Dec; 572():118786. PubMed ID: 31669214
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer.
Li YJ; Wu JY; Wang JM; Hu XB; Cai JX; Xiang DX
Acta Biomater; 2020 Jan; 101():519-530. PubMed ID: 31629893
[TBL] [Abstract][Full Text] [Related]
14. Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy.
Qi H; Liu C; Long L; Ren Y; Zhang S; Chang X; Qian X; Jia H; Zhao J; Sun J; Hou X; Yuan X; Kang C
ACS Nano; 2016 Mar; 10(3):3323-33. PubMed ID: 26938862
[TBL] [Abstract][Full Text] [Related]
15. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo.
Shi C; Cao H; He W; Gao F; Liu Y; Yin L
Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582
[TBL] [Abstract][Full Text] [Related]
16. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
[TBL] [Abstract][Full Text] [Related]
17. Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy.
Zhan Q; Yi K; Qi H; Li S; Li X; Wang Q; Wang Y; Liu C; Qiu M; Yuan X; Zhao J; Hou X; Kang C
Theranostics; 2020; 10(17):7889-7905. PubMed ID: 32685027
[No Abstract] [Full Text] [Related]
18. Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs.
Qiao L; Hu S; Huang K; Su T; Li Z; Vandergriff A; Cores J; Dinh PU; Allen T; Shen D; Liang H; Li Y; Cheng K
Theranostics; 2020; 10(8):3474-3487. PubMed ID: 32206102
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation
Wang Y; Guo M; Lin D; Liang D; Zhao L; Zhao R; Wang Y
Drug Deliv; 2021 Dec; 28(1):1510-1523. PubMed ID: 34263685
[TBL] [Abstract][Full Text] [Related]
20. Exosomes-coated bcl-2 siRNA inhibits the growth of digestive system tumors both in vitro and in vivo.
Tao H; Xu H; Zuo L; Li C; Qiao G; Guo M; Zheng L; Leitgeb M; Lin X
Int J Biol Macromol; 2020 Oct; 161():470-480. PubMed ID: 32531356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
